These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16020287)

  • 1. Interleukin-4 is not critical to pathogenesis in a mouse model of Pseudomonas aeruginosa corneal infection.
    Cole N; Hume E; Khan S; Krockenberger M; Thakur A; Husband AJ; Willcox MD
    Curr Eye Res; 2005 Jul; 30(7):535-42. PubMed ID: 16020287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Pseudomonas aeruginosa corneal infection in IL-1 beta converting enzyme (ICE, caspase-1) deficient mice.
    Thakur A; Barrett RP; McClellan S; Hazlett LD
    Curr Eye Res; 2004; 29(4-5):225-33. PubMed ID: 15590467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis.
    Huang X; Barrett RP; McClellan SA; Hazlett LD
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4209-16. PubMed ID: 16249500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis.
    Huang X; Du W; McClellan SA; Barrett RP; Hazlett LD
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4910-6. PubMed ID: 17065506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of IL-12 and IFN-gamma in Pseudomonas aeruginosa corneal infection.
    Hazlett LD; Rudner XL; McClellan SA; Barrett RP; Lighvani S
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):419-24. PubMed ID: 11818386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A protective role for IL-6 in staphylococcal microbial keratitis.
    Hume EB; Cole N; Garthwaite LL; Khan S; Willcox MD
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4926-30. PubMed ID: 17065508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection.
    Hazlett LD; McClellan SA; Barrett RP; Liu J; Zhang Y; Lighvani S
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):797-807. PubMed ID: 17251480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators downregulated.
    McClellan SA; Zhang Y; Barrett RP; Hazlett LD
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1502-11. PubMed ID: 18385069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection.
    McClellan SA; Huang X; Barrett RP; Lighvani S; Zhang Y; Richiert D; Hazlett LD
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):256-64. PubMed ID: 16384971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa MucD protease mediates keratitis by inhibiting neutrophil recruitment and promoting bacterial survival.
    Mochizuki Y; Suzuki T; Oka N; Zhang Y; Hayashi Y; Hayashi N; Gotoh N; Ohashi Y
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):240-6. PubMed ID: 24255043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-gamma: regulation of nitric oxide in the P. aeruginosa-infected cornea.
    McClellan SA; Lighvani S; Hazlett LD
    Ocul Immunol Inflamm; 2006 Feb; 14(1):21-8. PubMed ID: 16507487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of arachidonic acid metabolism and the polymorphonuclear leukocyte response in mice infected intracorneally with Pseudomonas aeruginosa.
    Kernacki KA; Berk RS
    Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):16-23. PubMed ID: 7822143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen Activators and Inhibitors in the Corneas of Mice Infected with Pseudomonas aeruginosa.
    Berk RS; Katar M; Dong Z; Day DE
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1561-7. PubMed ID: 11381061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive.
    Hazlett LD; McClellan S; Kwon B; Barrett R
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):805-10. PubMed ID: 10711697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal response to Pseudomonas aeruginosa infection.
    Hazlett LD
    Prog Retin Eye Res; 2004 Jan; 23(1):1-30. PubMed ID: 14766315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus type 37 keratitis in the C57BL/6J mouse.
    Chintakuntlawar AV; Astley R; Chodosh J
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):781-8. PubMed ID: 17251478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase-1 inhibitor reduces severity of pseudomonas aeruginosa keratitis in mice.
    Thakur A; Barrett RP; Hobden JA; Hazlett LD
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3177-84. PubMed ID: 15326138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nona-D-arginine therapy for Pseudomonas aeruginosa keratitis.
    Karicherla P; Hobden JA
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):256-62. PubMed ID: 18775859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved bacterial clearance and decreased mortality can be induced by LPS tolerance and is not dependent upon IFN-gamma.
    Murphey ED; Fang G; Varma TK; Sherwood ER
    Shock; 2007 Mar; 27(3):289-95. PubMed ID: 17304110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for TIMP-1 protection against P. aeruginosa-induced corneal ulceration and perforation.
    Kernacki KA; Barrett R; Hazlett LD
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3168-76. PubMed ID: 10586939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.